DOXGX | EAFVX | DOXGX / EAFVX | |
Total Expense Ratio | 0.41 | 0.99 | 41% |
Annual Report Gross Expense Ratio | 0.46 | 1.06 | 43% |
Fund Existence | 3 years | 15 years | - |
Gain YTD | 10.749 | 6.633 | 162% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 121B | 240M | 50,417% |
Annual Yield % from dividends | 1.42 | 1.06 | 133% |
Returns for 1 year | 4.99 | 0.07 | 6,815% |
Returns for 3 years | 43.47 | 24.83 | 175% |
Returns for 5 years | N/A | 39.48 | - |
Returns for 10 years | N/A | 64.67 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBMPX | 142.92 | N/A | N/A |
Fidelity Select Communication Services | |||
STSEX | 2713.73 | N/A | N/A |
BlackRock Exchange BlackRock | |||
FRBRX | 163.85 | N/A | N/A |
Franklin Biotechnology Discovery R6 | |||
PRCGX | 26.77 | N/A | N/A |
Perritt MicroCap Opportunities Investor | |||
MLAAX | 11.02 | -0.07 | -0.63% |
NYLI Winslow Large Cap Growth Class A |